Table 2

Individual characteristics of the breakthrough exercise-induced bronchoconstriction (EIB) group

Subject	Sex	Age (years)	Height (cm)	BMI z score	ICS	LABA	LTRA	Baseline FEV₁ (% predicted)	Time to ↓FEV₁ >15% (min)	↓FEV₁ at cessation (% from baseline)	↓FEV₁ t=1 (% from baseline)
1	F	11	156	1.3	+	−	+	81	7	−15	−47
2	F	8	137	1.2	+	−	+	91	6	−24	−28
3	F	9	141	0.1	+	+	−	84	6	−23	−54
4	F	8	132	2.0	+	+	−	74	6	−35	−45
5	M	15	168	1.9	+	+	−	89	8	−16	−32
6	M	12	155	−0.1	+	+	−	67	10	−18	−27
7	F	10	140	1.7	+	+	+	96	10	−17	−34
8	F	14	165	−0.4	+	−	+	84	8	−15	−34
9	M	11	138	0.4	+	+	−	85	9	−15	−45
10	M	11	162	0.1	+	+	−	69	10	−17	−17
11	M	13	163	2.4	+	−	−	94	6	−15	−21
12	M	13	175	−0.2	+	+	−	85	7	−19	−26

↓FEV₁ at cessation, fall in FEV₁ at cessation of exercise; ↓FEV₁ t=1, fall in FEV₁ 1 min after exercise; BMI, body mass index; F, female; FEV₁, forced expiratory volume in 1 s; ICS, inhaled corticosteroid; LABA, long acting bronchodilator agent; LTRA, leukotriene antagonist; M, male; time to ↓FEV₁ >15%, time to EIB during exercise.